Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL60P is a genomic pseudogene related to 7SL RNA, the non-coding RNA core of the signal recognition particle (SRP), which is essential for directing newly synthesized proteins to the endoplasmic reticulum. RN7SL60P is one of many 7SL RNA pseudogenes found throughout the human genome, arising through reverse transcription and genomic integration of 7SL RNA molecules. Unlike the functional 7SL RNA gene, pseudogenes like RN7SL60P lack the ability to produce functional RNA and are not involved in canonical SRP-mediated cellular processes. Pseudogenes generally do not encode proteins or functional RNAs and are not currently recognized as therapeutic targets, receptors, or enzymes. No direct involvement of RN7SL60P in disease or as a clinical biomarker has been described in the scientific literature.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 60, pseudogene (RN7SL60P).